Olanzapine EP Impurity A is a structurally related synthetic byproduct derived from the antipsychotic drug olanzapine, characterized by a substituted dibenzazepine core with a piperazine moiety and a sulfonyl group. Its molecular architecture features a 2-chlorophenyl ring linked to a piperazine ring via a sulfonyl bridge, with an additional amide functionality at the 11-position of the azepine ring. This impurity arises from incomplete alkylation during olanzapine synthesis, retaining a sulfonamide precursor fragment. The compound exhibits distinct UV absorption maxima due to conjugated aromatic systems and serves as a critical HPLC reference standard for quantifying process-related impurities in olanzapine drug substance batches.
